The Drug Information Association has announced its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies.
The conference will be held January 11-13, 2010 at the Renaissance Washington DC Hotel, Washington, DC.
Information from the DIA Website:
This comprehensive three-day program will discuss the current complexities and controversies in pharmacovigilance and risk management throughout all phases of development and marketed use, how to optimally utilize epidemiological, clinical pharmacological and other techniques, risk management strategies, and how to create an effective organizational “system.” This program will focus primarily on drug products and biologics, but medical devices will have a limited role in the discussions.
Featured Topics
• Latest international regulatory developments
• How to generate and assess critical safety data during development
• Compliance with clinical safety and post-marketing pharmacovigilance
regulatory requirements in an evolving global environment
• Recent multinational initiatives under the International Conference
on Harmonization (ICH) and Council for International Organizations
of Medical Sciences (CIOMS) on Drug Safety Update Reports
(DSURs) in premarketing clinical trial safety
• New approaches in risk management, risk communication, labeling
and packaging to optimize medical product benefit while minimizing
preventable harm
Please see the brochure below for registration information:
dia-pharmacovigilance-conference-brochure.pdf
